These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23364630)

  • 1. Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality.
    Sánchez-Villanueva R; Estrada P; del Peso G; Grande C; Díez JJ; Iglesias P; González E; Aguilar-Rodríguez A; Selgas R; Bajo MA; ;
    Nefrologia; 2013 Jan; 33(1):85-92. PubMed ID: 23364630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.
    Martins C; Mazza do Nascimento M; Pecoits-Filho R; Leinig C; Gonçalves LF; Fuerbringer R; Stenvinkel P; Lindholm B; Riella MC
    J Ren Nutr; 2007 Mar; 17(2):132-7. PubMed ID: 17321953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.
    Becker B; Kronenberg F; Kielstein JT; Haller H; Morath C; Ritz E; Fliser D;
    J Am Soc Nephrol; 2005 Apr; 16(4):1091-8. PubMed ID: 15743998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and Correlation of Indices of Insulin Resistance in Patients on Peritoneal Dialysis.
    King-Morris KR; Deger SM; Hung AM; Egbert PA; Ellis CD; Graves A; Shintani A; Ikizler TA
    Perit Dial Int; 2016; 36(4):433-41. PubMed ID: 26526047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
    Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
    Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.
    Li Y; Zhang L; Gu Y; Hao C; Zhu T
    Perit Dial Int; 2013; 33(4):411-8. PubMed ID: 23455976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular comorbidity and mortality in patients starting peritoneal dialysis: an American midwestern center experience.
    Tan SH; Prowant BF; Khanna R; Nolph KD; Twardowski ZJ
    Adv Perit Dial; 2001; 17():142-7. PubMed ID: 11510263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients.
    Fried L; Bernardini J; Piraino B
    Am J Kidney Dis; 2001 Feb; 37(2):337-42. PubMed ID: 11157375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
    Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
    Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
    Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for vascular complications in patients on peritoneal dialysis.
    Arima H; Nakamoto H; Okada S; Inoue T; Kobayashi K; Shoda J; Ikeda N; Kanno Y; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():192-7. PubMed ID: 16983968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis.
    Sokunbi DO; Wadhwa NK; Suh H
    Adv Perit Dial; 1994; 10():77-80. PubMed ID: 7999869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.